WMSA
Weiss Multi-Strategy Advisers Portfolio holdings
AUM
$3.94B
1-Year Return
29.08%
This Quarter Return
+2.99%
1 Year Return
+29.08%
3 Year Return
+75.24%
5 Year Return
+223.81%
10 Year Return
+334.33%
AUM
$2.11B
AUM Growth
+$157M
(+8%)
Cap. Flow
+$118M
Cap. Flow
% of AUM
5.58%
Top 10 Holdings %
Top 10 Hldgs %
19.37%
Holding
565
New
168
Increased
81
Reduced
130
Closed
130
Top Buys
| 1 |
SITE Centers
SITC
|
+$48.4M |
| 2 |
VR
Validus Hold Ltd
VR
|
+$36.9M |
| 3 |
Regions Financial
RF
|
+$26M |
| 4 |
SL Green Realty
SLG
|
+$25.7M |
| 5 |
Mid-America Apartment Communities
MAA
|
+$25.1M |
Top Sells
| 1 |
Capital One
COF
|
+$45.4M |
| 2 |
Truist Financial
TFC
|
+$33.1M |
| 3 |
KeyCorp
KEY
|
+$31.3M |
| 4 |
Intercontinental Exchange
ICE
|
+$27.4M |
| 5 |
Dollar General
DG
|
+$26.2M |
Sector Composition
| 1 | Real Estate | 24.13% |
| 2 | Financials | 20.63% |
| 3 | Energy | 9.73% |
| 4 | Healthcare | 9.56% |
| 5 | Industrials | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GNMK
301
DELISTED
GenMark Diagnostics, Inc
GNMK
| $902K | 0.04% |
69,500
-5,500
| -7% | -$71.4K |
|
302
Oil States International
OIS
$341M
| $875K | 0.04% |
+22,000
| New | +$875K |
|
|
BCR
303
DELISTED
CR Bard Inc.
BCR
| $837K | 0.04% |
5,000
-5,000
| -50% | -$837K |
|
304
Rigel Pharmaceuticals
RIGL
$654M
| $821K | 0.04% |
23,000
+1,000
| +5% | +$35.7K |
|
305
HealthEquity
HQY
$7.88B
| $812K | 0.04% |
+32,500
| New | +$812K |
|
306
Trupanion
TRUP
$1.86B
| $800K | 0.04% |
100,000
+17,500
| +21% | +$140K |
|
307
Ligand Pharmaceuticals
LGND
$3.24B
| $771K | 0.03% |
16,030
| – | – |
|
|
KTWO
308
DELISTED
K2M Group Holdings, Inc
KTWO
| $761K | 0.03% |
34,500
+9,500
| +38% | +$210K |
|
|
SAGE
309
DELISTED
Sage Therapeutics
SAGE
| $753K | 0.03% |
+15,000
| New | +$753K |
|
310
Acacia Research
ACTG
$304M
| $752K | 0.03% |
+70,300
| New | +$752K |
|
|
XLRN
311
DELISTED
Acceleron Pharma Inc.
XLRN
| $742K | 0.03% |
+19,500
| New | +$742K |
|
|
MZOR
312
DELISTED
Mazor Robotics Ltd.
MZOR
| $730K | 0.03% |
65,000
-5,000
| -7% | -$56.2K |
|
313
Expeditors International
EXPD
$16.5B
| $723K | 0.03% |
15,000
-54,000
| -78% | -$2.6M |
|
314
MPLX
MPLX
$50.8B
| $711K | 0.03% |
+9,700
| New | +$711K |
|
|
QGENF
315
DELISTED
QIAGEN NV
QGENF
| $701K | 0.03% |
27,800
-2,200
| -7% | -$55.5K |
|
316
Molina Healthcare
MOH
$9.71B
| $673K | 0.03% |
10,000
+5,000
| +100% | +$337K |
|
317
Pacific Biosciences
PACB
$366M
| $642K | 0.03% |
110,000
+2,700
| +3% | +$15.8K |
|
318
Catalyst Pharmaceutical
CPRX
$2.42B
| $641K | 0.03% |
148,000
-12,000
| -8% | -$52K |
|
319
TG Therapeutics
TGTX
$5.05B
| $619K | 0.03% |
40,000
+4,000
| +11% | +$61.9K |
|
320
Traws Pharma
TRAW
$12.9M
| $581K | 0.03% |
4
+1
| +33% | +$145K |
|
321
AtriCure
ATRC
$1.75B
| $570K | 0.03% |
27,800
-2,200
| -7% | -$45.1K |
|
|
CPHD
322
DELISTED
Cepheid Inc
CPHD
| $569K | 0.03% |
10,000
| – | – |
|
323
Xoma
XOMA
$442M
| $540K | 0.02% |
7,420
-1,580
| -18% | -$115K |
|
|
ABCO
324
DELISTED
Advisory Board Co/The
ABCO
| $533K | 0.02% |
10,000
-10,000
| -50% | -$533K |
|
|
NNA
325
DELISTED
Navios Maritime Acquisition Corporation
NNA
| $520K | 0.02% |
+9,800
| New | +$520K |
|